FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| SKNV | 080105003 | 72934-4344 | 72934-4344-8 | Betamethasone Dipropionate; Minoxidil; Niacinamide; Pentoxifylline | .05 g/100 mL; 5 g/100 mL; 2 g/100 mL; .5 g/100 mL | 2024-2 | valid | 2026-10-13 | |
| SKNV | 72934-4344 | 72934-4344-8 | Oxopidaxiaqup Solution | 031016 BETAMETHASONE DIPROPIONATE 0.05% / MINOXIDIL 5% / NIACINAMIDE 2% / PENTOXIFYLLINE 0.5% Solution | .05 g/100 mL; 5 g/100 mL; 2 g/100 mL; .5 g/100 mL | 2024-2 | valid | 2026-09-18 | |
| SKNV | 080105003 | 72934-4344 | 72934-4344-8 | Betamethasone Dipropionate; Minoxidil; Niacinamide; Pentoxifylline | .05 g/100 mL; 5 g/100 mL; 2 g/100 mL; .5 g/100 mL | 2024-1 | valid | 2026-10-13 | |
| SKNV | 080105003 | 72934-4344 | 72934-4344-8 | Betamethasone Dipropionate; Minoxidil; Niacinamide; Pentoxifylline | .05 g/100 mL; 5 g/100 mL; 2 g/100 mL; .5 g/100 mL | 2023-2 | valid | 2026-10-13 |